GNI Group Ltd. (GNIIF)
15.50
0.00 (0.00%)
USD |
OTCM |
Oct 20, 16:00
GNI Group Net Income (Quarterly) : 17.50M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 17.50M |
| March 31, 2026 | -21.52M |
| December 31, 2025 | -32.93M |
| September 30, 2025 | 1.809M |
| June 30, 2025 | -7.441M |
| March 31, 2025 | -8.308M |
| December 31, 2024 | -4.051M |
| September 30, 2024 | 4.568M |
| June 30, 2024 | -9.100M |
| March 31, 2024 | 9.053M |
| December 31, 2023 | 31.77M |
| September 30, 2023 | 5.468M |
| June 30, 2023 | 31.67M |
| March 31, 2023 | -2.581M |
| December 31, 2022 | -8.434M |
| September 30, 2022 | 0.9145M |
| June 30, 2022 | 0.9676M |
| March 31, 2022 | 0.6215M |
| December 31, 2021 | -7.207M |
| September 30, 2021 | 1.182M |
| June 30, 2021 | 2.825M |
| March 31, 2021 | 4.107M |
| December 31, 2020 | 4.487M |
| September 30, 2020 | 3.488M |
| June 30, 2020 | 2.497M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.371M |
| December 31, 2019 | -0.9748M |
| September 30, 2019 | 2.187M |
| June 30, 2019 | 2.383M |
| March 31, 2019 | 2.172M |
| December 31, 2018 | -0.1046M |
| September 30, 2018 | 1.885M |
| June 30, 2018 | 2.326M |
| March 31, 2018 | -2.402M |
| December 31, 2017 | 2.147M |
| September 30, 2017 | -0.0432M |
| June 30, 2017 | -0.3171M |
| March 31, 2017 | -1.534M |
| December 31, 2016 | 2.235M |
| September 30, 2016 | -0.6316M |
| June 30, 2016 | -3.465M |
| March 31, 2016 | -2.361M |
| September 30, 2015 | -1.538M |
| June 30, 2015 | -1.155M |
| March 31, 2015 | -1.272M |
| December 31, 2014 | 0.9185M |
| September 30, 2014 | -1.028M |
| June 30, 2014 | -1.378M |
| March 31, 2014 | -1.500M |
| December 31, 2013 | -2.042M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| 3-D Matrix Ltd. | 1.888M |
| Healios KK | 7.474M |
| AnGes, Inc. | -10.24M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alkermes Plc | 0.501M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 40.23M |
| Total Expenses (Quarterly) | 39.35M |
| EPS Diluted (Quarterly) | 0.0156 |
| Enterprise Value | 951.27M |
| Gross Profit Margin (Quarterly) | 71.81% |
| Profit Margin (Quarterly) | 43.49% |
| Earnings Yield | -3.96% |
| Normalized Earnings Yield | -3.959 |